These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 29401749)
1. The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition. Schnekenburger M; Mathieu V; Lefranc F; Jang JY; Masi M; Kijjoa A; Evidente A; Kim HJ; Kiss R; Dicato M; Han BW; Diederich M Molecules; 2018 Feb; 23(2):. PubMed ID: 29401749 [TBL] [Abstract][Full Text] [Related]
2. Carprofen analogues as sirtuin inhibitors: enzyme and cellular studies. Mellini P; Carafa V; Di Rienzo B; Rotili D; De Vita D; Cirilli R; Gallinella B; Provvisiero DP; Di Maro S; Novellino E; Altucci L; Mai A ChemMedChem; 2012 Nov; 7(11):1905-8. PubMed ID: 24155041 [TBL] [Abstract][Full Text] [Related]
3. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT. Yagci S; Gozelle M; Kaya SG; Ozkan Y; Aksel AB; Bakar-Ates F; Dundar Y; Eren G Bioorg Med Chem; 2021 Jan; 30():115961. PubMed ID: 33360574 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton. Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955 [TBL] [Abstract][Full Text] [Related]
5. Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2. Galli U; Mesenzani O; Coppo C; Sorba G; Canonico PL; Tron GC; Genazzani AA Eur J Med Chem; 2012 Sep; 55():58-66. PubMed ID: 22835719 [TBL] [Abstract][Full Text] [Related]
6. Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors. Yang L; Ma X; Yuan C; He Y; Li L; Fang S; Xia W; He T; Qian S; Xu Z; Li G; Wang Z Eur J Med Chem; 2017 Jul; 134():230-241. PubMed ID: 28415012 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in inhibitors of sirtuin1/2: an update and perspective. Zhou Z; Ma T; Zhu Q; Xu Y; Zha X Future Med Chem; 2018 Apr; 10(8):907-934. PubMed ID: 29642711 [TBL] [Abstract][Full Text] [Related]
8. Virtual screening approach of sirtuin inhibitors results in two new scaffolds. Kokkonen P; Kokkola T; Suuronen T; Poso A; Jarho E; Lahtela-Kakkonen M Eur J Pharm Sci; 2015 Aug; 76():27-32. PubMed ID: 25936698 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines. Ceballos MP; Decándido G; Quiroga AD; Comanzo CG; Livore VI; Lorenzetti F; Lambertucci F; Chazarreta-Cifre L; Banchio C; Alvarez ML; Mottino AD; Carrillo MC Toxicol Lett; 2018 Jun; 289():63-74. PubMed ID: 29545174 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and cell death mechanisms induced by a novel bisnaphthalimidopropyl derivative against the NCI-H460 non-small lung cancer cell line. Lima RT; Barron GA; Grabowska JA; Bermano G; Kaur S; Roy N; Vasconcelos MH; Lin PK Anticancer Agents Med Chem; 2013 Mar; 13(3):414-21. PubMed ID: 23092269 [TBL] [Abstract][Full Text] [Related]
11. Current advances in the synthesis and antitumoral activity of SIRT1-2 inhibitors by modulation of p53 and pro-apoptotic proteins. Botta G; De Santis LP; Saladino R Curr Med Chem; 2012; 19(34):5871-84. PubMed ID: 22998567 [TBL] [Abstract][Full Text] [Related]
12. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells. Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526 [TBL] [Abstract][Full Text] [Related]
13. Discovery and characterization of small molecule SIRT3-specific inhibitors as revealed by mass spectrometry. Loharch S; Chhabra S; Kumar A; Swarup S; Parkesh R Bioorg Chem; 2021 May; 110():104768. PubMed ID: 33676042 [TBL] [Abstract][Full Text] [Related]
14. The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease model. Di Fruscia P; Zacharioudakis E; Liu C; Moniot S; Laohasinnarong S; Khongkow M; Harrison IF; Koltsida K; Reynolds CR; Schmidtkunz K; Jung M; Chapman KL; Steegborn C; Dexter DT; Sternberg MJ; Lam EW; Fuchter MJ ChemMedChem; 2015 Jan; 10(1):69-82. PubMed ID: 25395356 [TBL] [Abstract][Full Text] [Related]
15. Tetrahydroindoles as Multipurpose Screening Compounds and Novel Sirtuin Inhibitors. Vojacek S; Schulig L; Wössner N; Geist N; Langel W; Jung M; Schade D; Link A ChemMedChem; 2019 Apr; 14(8):853-864. PubMed ID: 30811852 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors that target tubulin. Schemies J; Sippl W; Jung M Cancer Lett; 2009 Aug; 280(2):222-32. PubMed ID: 19268440 [TBL] [Abstract][Full Text] [Related]
17. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer. Hoffmann G; Breitenbücher F; Schuler M; Ehrenhofer-Murray AE J Biol Chem; 2014 Feb; 289(8):5208-16. PubMed ID: 24379401 [TBL] [Abstract][Full Text] [Related]
18. Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer. Carafa V; Poziello A; Della Torre L; Giovannelli P; Di Donato M; Safadeh E; Yu Z; Baldi A; Castoria G; Tomaselli D; Mai A; Rotili D; Nebbioso A; Altucci L Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726691 [TBL] [Abstract][Full Text] [Related]
19. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. Feldman JL; Baeza J; Denu JM J Biol Chem; 2013 Oct; 288(43):31350-6. PubMed ID: 24052263 [TBL] [Abstract][Full Text] [Related]
20. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth. Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]